Dexmedetomidine has emerged as a promising sedative agent for mechanically ventilated pediatric patients; however, its benefits and safety profile compared with conventional sedatives remain challenging to establish. To address this issue, a comparative study involving 130 pediatric patients evaluated the efficacy and safety of Dexmedetomidine versus Midazolam for achieving deep sedation in children receiving mechanical ventilation. The study found that Dexmedetomidine was less effective than Midazolam in achieving target sedation levels across all pediatric age groups.
In infants younger than one year, however, no significant difference in sedation effectiveness was observed between the two medications. Patients receiving Dexmedetomidine required higher drug doses and more frequent dose adjustments over 6 hours to maintain adequate sedation, whereas the Midazolam group required fewer…
